ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 632,71
0,00%
Dow Jones
40 211,72
0,53%
DAX
18 590,89
-0,95%
Brent Oil
83,72
-0,74%
Bitcoin
63 800,91
-1,62%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
22/06/201614h20PR Newswire (US)Biotechnology Stocks in Motion -- Minerva Neurosciences, Portola Pharma, Trevena, and Anthera PharmaNASDAQ:PTLAPortola Pharmaceuticals Inc
21/06/201623h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
14/06/201612h05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
01/06/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Dosing of First Patient in Phase 2a Study of Cerdulatinib for Treatment of Hematologic Canc...NASDAQ:PTLAPortola Pharmaceuticals Inc
31/05/201622h05GlobeNewswire Inc.Portola Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
27/05/201614h45GlobeNewswire Inc.Portola Pharmaceuticals Announces Full Results of Phase 3 APEX Study of Betrixaban Presented at International Society on Thro...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/05/201618h23Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PTLAPortola Pharmaceuticals Inc
23/05/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Data Presentations on Betrixaban and AndexXa™ (andexanet alfa) at International ...NASDAQ:PTLAPortola Pharmaceuticals Inc
19/05/201614h35PR Newswire (US)How are Investors Treating These Biotech? - Portola Pharma, Vitae Pharma, Anthera Pharma, and Intra-Cellular TherapiesNASDAQ:PTLAPortola Pharmaceuticals Inc
06/05/201612h19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/201622h43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/05/201622h05GlobeNewswire Inc.Portola Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
29/04/201622h40Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTLAPortola Pharmaceuticals Inc
28/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce First Quarter 2016 Financial Results and Host Conference Call on Thursday, May 5NASDAQ:PTLAPortola Pharmaceuticals Inc
14/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Upcoming Cerdulatinib Data Presentation at American Association for Cancer Research (AACR) ...NASDAQ:PTLAPortola Pharmaceuticals Inc
11/04/201617h57Edgar (US Regulatory)Schedule 13gNASDAQ:PTLAPortola Pharmaceuticals Inc
06/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Presentation of Phase 3 APEX Study Results at International Society on Thrombosis and Haemo...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/04/201614h00GlobeNewswire Inc.Portola Pharmaceuticals Enters Into Clinical Collaboration Agreement with Daiichi Sankyo to Develop Andexanet Alfa with Edoxa...NASDAQ:PTLAPortola Pharmaceuticals Inc
30/03/201617h50Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201614h44Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201614h40Dow Jones NewsPortola's Shares Plunge on Blood Clot TrialNASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201612h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Topline Results from Phase 3 APEX Trial of Betrixaban for Prevention of Blood Clots in Acut...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/03/201609h00GlobeNewswire Inc.Portola Pharmaceuticals to Hold Conference Call on Thursday, March 24, at 8:30 am ETNASDAQ:PTLAPortola Pharmaceuticals Inc
10/03/201601h46GlobeNewswire Inc.Portola Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
10/03/201601h46GlobeNewswire Inc.Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
29/02/201623h19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTLAPortola Pharmaceuticals Inc
19/02/201614h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2015 Financial Results and Host Conference Call on Friday, Fe...NASDAQ:PTLAPortola Pharmaceuticals Inc
17/02/201623h42GlobeNewswire Inc.Portola Pharmaceuticals Announces Biologics License Application for Andexanet Alfa Accepted for Review by FDANASDAQ:PTLAPortola Pharmaceuticals Inc
12/02/201623h35Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
12/02/201615h27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

BIT
P235N0
NLBNPIT235N0 20241218 5400
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés